Amylin Pharmaceuticals

Organisation

Trials

  • NCT01588418

    Collaborator, Phase 4, Completed, 15 people, 1 May 2012

  • NCT01501084

    Collaborator, Phase 1, Completed, 34 people, 29 Dec 2011

  • NCT01381926

    Collaborator, Phase 4, Terminated, 14 people, 27 Jun 2011

  • NCT01268644

    Collaborator, Phase 1, Terminated, 8 people, 31 Dec 2010

  • NCT01181986

    Collaborator, Phase 4, Completed, 76 people, 16 Aug 2010

  • NCT01154933

    Collaborator, Phase 2, Completed, 24 people, 1 Jul 2010

  • NCT01107717

    Collaborator, Phase 4, Completed, 318 people, 21 Apr 2010

  • NCT01061775

    Collaborator, Phase 1/2, Completed, 19 people, 3 Feb 2010

  • NCT01006889

    Collaborator, Phase 4, Completed, 24 people, 3 Nov 2009

  • NCT00882050

    Collaborator, Phase 1/2, Completed, 104 people, 16 Apr 2009

  • NCT00845559

    Collaborator, Phase 4, Withdrawn, 0 people, 18 Feb 2009

  • NCT00736229

    Collaborator, Phase 4, Completed, 40 people, 15 Aug 2008

  • NCT00710814

    Collaborator, Phase 1/2, Completed, 31 people, 4 Jul 2008

  • NCT00667732

    Collaborator, Phase 4, Completed, 41 people, 28 Apr 2008

  • NCT00546728

    Collaborator, Phase 4, Completed, 50 people, 19 Oct 2007

  • NCT00529204

    Collaborator, Phase 2, Terminated, 1 person, 14 Sept 2007

  • NCT00461552

    Collaborator, Phase 2, Completed, 23 people, 18 Apr 2007

  • NCT00456885

    Collaborator, Phase 4, Completed, 41 people, 5 Apr 2007

  • NCT00442767

    Collaborator, Phase 4, Completed, 8 people, 2 Mar 2007

  • NCT00353834

    Collaborator, Phase 4, Completed, 72 people, 19 Jul 2006